Your browser doesn't support javascript.
loading
In vitro and in vivo activity of cefiderocol against Achromobacter spp. and Burkholderia cepacia complex, including carbapenem-non-susceptible isolates.
Takemura, Miki; Nakamura, Rio; Ota, Merime; Nakai, Ryuichiro; Sahm, Daniel F; Hackel, Meredith A; Yamano, Yoshinori.
Affiliation
  • Takemura M; Laboratory for Drug Discovery and Disease Research, Shionogi & Co., Ltd., Osaka, Japan.
  • Nakamura R; Department of Biofunctional Evaluation ΙI, Shionogi TechnoAdvance Research & Co., Ltd., Osaka, Japan.
  • Ota M; Department of Biofunctional Evaluation ΙI, Shionogi TechnoAdvance Research & Co., Ltd., Osaka, Japan.
  • Nakai R; Department of Biofunctional Evaluation ΙI, Shionogi TechnoAdvance Research & Co., Ltd., Osaka, Japan.
  • Sahm DF; International Health Management Associates, Schaumburg, Illinois, USA.
  • Hackel MA; International Health Management Associates, Schaumburg, Illinois, USA.
  • Yamano Y; Laboratory for Drug Discovery and Disease Research, Shionogi & Co., Ltd., Osaka, Japan.
Antimicrob Agents Chemother ; 67(12): e0034623, 2023 12 14.
Article in En | MEDLINE | ID: mdl-37971240

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Tract Infections / Achromobacter / Burkholderia cepacia complex Limits: Animals Language: En Journal: Antimicrob Agents Chemother Year: 2023 Document type: Article Affiliation country: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Tract Infections / Achromobacter / Burkholderia cepacia complex Limits: Animals Language: En Journal: Antimicrob Agents Chemother Year: 2023 Document type: Article Affiliation country: Japan